AzTrials
AzTrials

Inguinal HerniaNCT01592942

Mesh Fixation in Lichtenstein Hernioplasty

A study testing Histoacryl, Progrip and sutures (prolene 3-0) in people with Inguinal Hernia, run by Kuopio University Hospital at 1 site in Finland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is a prospective, randomized multi-centre study to find out most safe, feasible, painless and cost-effective mesh fixation method in inguinal hernia operation. Three mesh fixation techniques are compared to find out best technique in local anaesthesia Lichtenstein operation. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Inguinal Hernia
What is being tested?
Histoacryl, Progrip and sutures (prolene 3-0)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
650 participants
Where
1 siteFinland
Study dates
Aug 2012to Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • primary or recurrent inguinal hernia
  • unilateral or bilateral

Who cannot join

  • femoral hernia
  • massive scrotal hernia
  • allergy to polypropylene
  • patient's refusal

Trial locations and contacts

1 site in 1 country.

Hannu EK Paajanen, MD, PhD contact

+358-40-3589905

hannu.paajanen@kuh.fi

Kirsi Rönkä, MD contact

kirsi.ronka@kuh.fi

Finland1 site, 1 recruiting
  • Kuopio University Hospital

    Kuopio, 70600

    Hannu EK Paajanen, MD, PhD, +358-40-3589905, hannu.paajanen@kuh.fi

    Kirsi Rönkä, MD, kirsi.ronka@kuh.fi

    Recruiting

Other trials in Finland

About this study

Official title: A Randomized Multi-center Study of Tissue Glue Fixation of Optilene™ Mesh With Histoacryl™ or Self-gripping Parietex ProGrip™ Compared to Conventional Non-absorbable Suture Fixation of Ultrapro™ Mesh

This is a prospective, randomized multi-centre study to find out most safe, feasible, painless and cost-effective mesh fixation method in inguinal hernia operation. Three mesh fixation techniques are compared to find out best technique in local anaesthesia Lichtenstein operation. Our hypothesis is that glue fixation is safe, simple and cheap method compared to conventional Lichtenstein technique.

Read the detailed description

Some 650 patients with inguinal hernia are operated using Lichtenstein operation in local anaesthesia. Mesh fixation is performed using 3 methods: Optilene™ mesh + cyanoacrylate glue (n=200), self-fixing Parietex Progrip™ mesh (n=200) and non-absorbable sutures with Ultrapro™ mesh (n=200). Operative time and pain scores, immediate postoperative outcome, quality-of-life and total costs are followed 1, 7, 30 days and 1 and 5 years postoperatively.

Conditions
Inguinal Hernia
Being tested
Histoacryl, Progrip, sutures (prolene 3-0)
Keywords
inguinal hernia, mesh fixation, glue, Lichtenstein
Medical subject headings
Hernia, Inguinal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HistoacrylDevice

    Also called Histoacryl glue

    cyanoacrylate glue fixation of mesh 1 ml

  • ProgripDevice

    Also called Parietex Progrip

    self-gripping mesh

  • sutures (prolene 3-0)Device

    Also called prolene 3-0

    non-absorbable suture fixation 3-0

Study groups in NCT01592942
Study groupRoleWhat they receive
glue fixationExperimentalOptilene™ mesh 60 g/m2 (B. Braun), fixation Histoacryl™ cyanoacrylate glue (price 14+37 euros)
Receives: Device: Histoacryl
self-grippingActive comparatorProGrip™ mesh 60 g/m2 (Covidien, USA) (price 113 euros)
Receives: Device: Progrip
suture fixationActive comparatorUltrapro™ mesh 28 g/m2 (Ethicon, USA) (price 45 euros) fixated by non-absorbable sutures
Receives: Device: sutures (prolene 3-0)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain

    pain scores (VAS 0-10) preoperatively and after surgery

    Measured: 5 years

Secondary outcomes (1)
  1. costs

    operative cost-effectiveness

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2012 (estimated)
  2. Study startAug 2012
  3. Primary completionMar 2019
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
650 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01592942
Sponsor's protocol ID
KUH5200627
Other IDs
KUH 31//2012
Status last verified
Dec 2020
First submitted
3 May 2012
Last updated
17 Dec 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Histoacryl, Progrip and sutures (prolene 3-0) in people with Inguinal Hernia, run by Kuopio University Hospital at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hannu EK Paajanen, MD, PhD (+358-40-3589905, hannu.paajanen@kuh.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain (time frame: 5 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Dec 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in